TABLE OF CONTENTS
1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.3 OVERVIEW 25
1.4 CURRENCY AND PRICING 27
1.5 LIMITATIONS 27
1.6 MARKETS COVERED 27
2 MARKET SEGMENTATION 30
2.1 MARKETS COVERED 30
2.2 GEOGRAPHICAL SCOPE 31
2.3 YEARS CONSIDERED FOR THE STUDY 32
2.4 DBMR TRIPOD DATA VALIDATION MODEL 33
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
2.6 MULTIVARIATE MODELLING 37
2.7 MARKET END USER COVERAGE GRID 38
2.8 PRODUCT LIFELINE CURVE 39
2.9 DBMR MARKET POSITION GRID 40
2.10 VENDOR SHARE ANALYSIS 41
2.11 SECONDARY SOURCES 42
2.12 ASSUMPTIONS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 PORTER'S FIVE FORCES MODEL 49
4.2 ECOSYSTEMS ANALYSIS OF E CLINICAL SOLUTIONS 50
4.3 USE CASES 52
5 VALUE CHAIN ANALYSIS 53
6 GLOBAL E-CLINICAL SOLUTIONS MARKET: REGULATIONS 54
7 MARKET OVERVIEW 60
7.1 DRIVERS 62
7.1.1 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS 62
7.1.2 INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE 62
7.1.3 STRATEGIC INITIATIVES TAKEN BY MAJOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 63
7.1.4 IMPROVED HEALTHCARE INFRASTRUCTURE AND ESTABLISHMENT OF ADVANCED LABORATORIES 63
7.2 RESTRAINTS 64
7.2.1 DATA SAFETY AND PRIVACY ISSUES 64
7.2.2 LACK OF SKILLED PROFESSIONALS 64
7.2.3 LIMITED ADOPTION OF E-CLINICAL SOLUTIONS IN EMERGING COUNTRIES DUE TO BUDGETARY CONSTRAINTS AND POOR MANAGEMENT POLICIES 65
7.3 OPPORTUNITIES 65
7.3.1 RISING ADOPTION OF ELECTRONIC DATA CAPTURE (EDC) SYSTEMS AND CLOUD-BASED SOLUTIONS 65
7.3.2 INCREASING INVESTMENTS BY VARIOUS GOVERNMENTS IN CLINICAL TRIALS 66
7.3.3 GROWING FOCUS ON PATIENT-CENTRIC CLINICAL TRIALS 66
7.4 CHALLENGES 67
7.4.1 REGULATORY CHALLENGES ASSOCIATED WITH E-CLINICAL SOLUTIONS 67
7.4.2 HIGH IMPLEMENTATION COSTS 67
8 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY PRODUCT 69
8.1 OVERVIEW 70
8.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS 73
8.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT 74
8.4 CLINICAL TRIAL MANAGEMENT SYSTEMS 75
8.5 ELECTRONIC TRIAL MASTER FILE SYSTEMS 76
8.6 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS 77
8.7 SAFETY SOLUTIONS 78
8.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS 79
8.9 CLINICAL DATA INTEGRATION PLATFORMS 80
8.10 CLINICAL ANALYTICS PLATFORMS 81
8.11 CARE COORDINATION MEDICAL RECORD (CCMR) 82
8.12 OTHERS 83
9 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE 85
9.1 OVERVIEW 86
9.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS 89
9.3 CLOUD-BASED (SAAS) SOLUTIONS 89
9.4 LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS 90
10 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE 92
10.1 OVERVIEW 93
10.2 PHASE III 96
10.3 PHASE I 96
10.4 PHASE II 97
10.5 PHASE IV 98
11 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE 99
11.1 OVERVIEW 100
11.2 MEDIUM AND SMALL 103
11.3 LARGE 104
12 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE 105
12.1 OVERVIEW 106
12.2 DESKTOP 109
12.3 TABLET 109
12.4 SMART PHONE 110
12.5 HANDHELD PDA DEVICE 111
12.6 OTHERS 111
13 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY END USER 113
13.1 OVERVIEW 114
13.2 CONTRACT RESEARCH ORGANIZATIONS 117
13.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 117
13.4 MEDICAL DEVICE MANUFACTURERS 118
13.5 HOSPITAL 119
13.6 CONSULTING SERVICE COMPANIES 119
13.7 ACADEMIC RESEARCH INSTITUTES 120
14 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY REGION 121
14.1 OVERVIEW 122
14.2 NORTH AMERICA 127
14.2.1 U.S. 134
14.2.2 CANADA 137
14.2.3 MEXICO 140
14.3 EUROPE 143
14.3.1 GERMANY 151
14.3.2 FRANCE 154
14.3.3 U.K. 157
14.3.4 ITALY 160
14.3.5 SPAIN 163
14.3.6 RUSSIA 166
14.3.7 TURKEY 169
14.3.8 NETHERLANDS 172
14.3.9 BELGIUM 175
14.3.10 SWITZERLAND 178
14.3.11 REST OF EUROPE 181
14.4 ASIA-PACIFIC 182
14.4.1 JAPAN 190
14.4.2 CHINA 193
14.4.3 INDIA 196
14.4.4 SOUTH KOREA 199
14.4.5 AUSTRALIA 202
14.4.6 SINGAPORE 205
14.4.7 THAILAND 208
14.4.8 MALAYSIA 211
14.4.9 INDONESIA 214
14.4.10 PHILIPPINES 217
14.4.11 REST OF ASIA-PACIFIC 220
14.5 SOUTH AMERICA 221
14.5.1 BRAZIL 229
14.5.2 ARGENTINA 231
14.5.3 REST OF SOUTH AMERICA 234
14.6 MIDDLE EAST AND AFRICA 235
14.6.1 SOUTH AFRICA 242
14.6.2 SAUDI ARABIA 245
14.6.3 U.A.E. 248
14.6.4 EGYPT 251
14.6.5 ISRAEL 254
14.6.6 REST OF MIDDLE EAST AND AFRICA 257
15 GLOBAL E-CLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE 258
15.1 COMPANY SHARE ANALYSIS: GLOBAL 258
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 259
15.3 COMPANY SHARE ANALYSIS: EUROPE 260
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 261
16 SWOT ANALYSIS 262
17 COMPANY PROFILE 263
17.1 ORACLE 263
17.1.1 COMPANY SNAPSHOT 263
17.1.2 REVENUE ANALYSIS 263
17.1.3 COMPANY SHARE ANALYSIS 264
17.1.4 PRODUCT PORTFOLIO 264
17.1.5 RECENT DEVELOPMENT 264
17.2 DASSAULT SYSTEMES 265
17.2.1 COMPANY SNAPSHOT 265
17.2.2 REVENUE ANALYSIS 265
17.2.3 COMPANY SHARE ANALYSIS 266
17.2.4 PRODUCT PORTFOLIO 266
17.2.5 RECENT DEVELOPMENTS 267
17.3 CLARIO 268
17.3.1 COMPANY SNAPSHOT 268
17.3.2 COMPANY SHARE ANALYSIS 268
17.3.3 PRODUCT PORTFOLIO 269
17.3.4 RECENT DEVELOPMENT 269
17.4 VEEVA SYSTEMS 270
17.4.1 COMPANY SNAPSHOT 270
17.4.2 REVENUE ANALYSIS 270
17.4.3 COMPANY SHARE ANALYSIS 271
17.4.4 PRODUCT PORTFOLIO 271
17.4.5 RECENT DEVELOPMENTS 272
17.5 ARISGLOBAL 273
17.5.1 COMPANY SNAPSHOT 273
17.5.2 COMPANY SHARE ANALYSIS 273
17.5.3 PRODUCT PORTFOLIO 274
17.5.4 RECENT DEVELOPMENTS 274
17.6 4G CLINICAL 275
17.6.1 COMPANY SNAPSHOT 275
17.6.2 PRODUCT PORTFOLIO 275
17.6.3 RECENT DEVELOPMENT 275
17.7 ADVARRA. 276
17.7.1 COMPANY SNAPSHOT 276
17.7.2 PRODUCT PORTFOLIO 276
17.7.3 RECENT DEVELOPMENT 276
17.8 ANJU 277
17.8.1 COMPANY SNAPSHOT 277
17.8.2 PRODUCT PORTFOLIO 277
17.8.3 RECENT DEVELOPMENTS 278
17.9 CASTOR. 279
17.9.1 COMPANY SNAPSHOT 279
17.9.2 PRODUCT PORTFOLIO 279
17.9.3 RECENT DEVELOPMENTS 279
17.10 DATATRAK INT. 280
17.10.1 COMPANY SNAPSHOT 280
17.10.2 PRODUCT PORTFOLIO 280
17.10.3 RECENT DEVELOPMENT 280
17.11 ECLINICAL SOLUTIONS LLC. 281
17.11.1 COMPANY SNAPSHOT 281
17.11.2 PRODUCT PORTFOLIO 281
17.11.3 RECENT DEVELOPMENT 281
17.12 IQVIA INC 282
17.12.1 COMPANY SNAPSHOT 282
17.12.2 REVENUE ANALYSIS 282
17.12.3 PRODUCT PORTFOLIO 283
17.12.4 RECENT DEVELOPMENTS 283
17.13 MAXISIT 284
17.13.1 COMPANY SNAPSHOT 284
17.13.2 PRODUCT PORTFOLIO 284
17.13.3 RECENT DEVELOPMENT 285
17.14 MEDNET 286
17.14.1 COMPANY SNAPSHOT 286
17.14.2 PRODUCT PORTFOLIO 286
17.14.3 RECENT DEVELOPMENT 287
17.15 MEDRIO, INC. 288
17.15.1 COMPANY SNAPSHOT 288
17.15.2 PRODUCT PORTFOLIO 288
17.15.3 RECENT DEVELOPMENTS 289
17.16 MERATIVE 290
17.16.1 COMPANY SNAPSHOT 290
17.16.2 PRODUCT PORTFOLIO 290
17.16.3 RECENT DEVELOPMENT 290
17.17 OPENCLINICA, LLC 291
17.17.1 COMPANY SNAPSHOT 291
17.17.2 PRODUCT PORTFOLIO 291
17.17.3 RECENT DEVELOPMENT 291
17.18 PAREXEL INTERNATIONAL CORPORATION 292
17.18.1 COMPANY SNAPSHOT 292
17.18.2 PRODUCT PORTFOLIO 292
17.18.3 RECENT DEVELOPMENT 292
17.19 QURETEC 293
17.19.1 COMPANY SNAPSHOT 293
17.19.2 PRODUCT PORTFOLIO 293
17.19.3 RECENT DEVELOPMENT 293
17.20 REALTIME SOFTWARE SOLUTIONS, LLC 294
17.20.1 COMPANY SNAPSHOT 294
17.20.2 PRODUCT PORTFOLIO 294
17.20.3 RECENT DEVELOPMENT 294
17.21 RESEARCH MANAGER 295
17.21.1 COMPANY SNAPSHOT 295
17.21.2 PRODUCT PORTFOLIO 295
17.21.3 RECENT DEVELOPMENT 295
17.22 SAAMA TECHNOLOGIES, LLC 296
17.22.1 COMPANY SNAPSHOT 296
17.22.2 PRODUCT PORTFOLIO 296
17.22.3 RECENT DEVELOPMENT 296
17.23 SIGNANT HEALTH 297
17.23.1 COMPANY SNAPSHOT 297
17.23.2 PRODUCT PORTFOLIO 297
17.23.3 RECENT DEVELOPMENT 297
17.24 Y-PRIME, LLC. 298
17.24.1 COMPANY SNAPSHOT 298
17.24.2 PRODUCT PORTFOLIO 298
17.24.3 RECENT DEVELOPMENT 298
18 QUESTIONNAIRE 299
19 RELATED REPORTS 302

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.